This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


PATH strives for vaccine equity in response to COVID-19

By Center for Vaccine Innovation and Access

When COVID-19 emerged, we mobilized quickly and deployed our decades of experience advancing equitable access to vaccines and immunization to support the global COVID-19 response.

Through the PATH Center for Vaccine Innovation and Access (CVIA), our COVID-19 work spans the full vaccine development to delivery spectrum, including supporting country vaccine readiness; COVAX and other efforts to ensure equitable access to vaccine; vaccine development and manufacturing scale-up; vaccine clinical evaluation; immunization system resiliency; and other efforts.